Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pomegranate juice components inhibit cancer cell migration; in vivo testing planned

13.12.2010
Research presented at American Society of Cell Biology's 50th annual meeting in Philadelphia

Researchers at the University of California, Riverside (UCR), have identified components in pomegranate juice that seem to inhibit the movement of cancer cells and weaken their attraction to a chemical signal that has been shown to promote the metastasis of prostate cancer to the bone, according to a presentation today at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia.

The researchers in the UCR laboratory of Manuela Martins-Green, Ph.D., plan additional testing in an in vivo model for prostate cancer to determine dose-dependent effects and side effects of the two components.

The effect, if any, of pomegranate juice on the progression of prostate cancer is controversial.

In a 2006 study of prostate cancer patients who daily drank an eight-ounce glass of pomegranate juice, UCLA researchers detected a decline in prostate-specific antigen (PSA) levels that suggested a potential slowing of cancer progression.

The UCLA researchers did not try to define the potential biological mechanism behind pomegranate juice's effects in the study.

In Sept. 2010, the Federal Trade Commission (FTC) filed suit against Pom Wonderful, the natural foods company that provided the pomegranate juice for the UCLA research and has supported other research on pomegranate juice. The FTC charged the company with making false and misleading claims about the juice's effects on health.

In previous studies, Martins-Green and her research team used a standardized concentration of pomegranate juice on two types of laboratory-cultured prostate cancer cells that were resistant to testosterone.

Resistance to the hormone indicates a potentially strong metastatic potential. The researchers noted not only increased cell death among the pomegranate juice-treated tumor cells but also increased cell adhesion and decreased cell migration in those cancer cells that had not died.

The Martins-Green lab next analyzed the fruit juice to identify the active ingredients that had a molecular impact on cell adhesion and migration in metastatic prostate cancer cells. Martins-Green, graduate student Lei Wang and undergraduate student Jeffrey Ho identified phenylpropanoids, hydrobenzoic acids, flavones and conjugated fatty acids.

"This is particularly exciting because we can now modify these naturally occurring components of the juice to improve their functions and make them more effective in preventing prostate cancer metastasis," said Martins-Green.

"Because the genes and proteins involved in movement of prostate cancer cells are essentially the same as those involved in movement of other types of cancer cells, the same modified components of the juice could have a much broader impact in cancer treatment," she said.

For more information:

ASCB contacts:

Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814 (cell)
215-418-5306 (Dec. 11-16)
John Fleischman
jfleischman@ascb.org
513-929-4635 (before Dec. 11)
513-706-0212 (cell)
University of California at Riverside contacts:
Manuela Martins-Green, Ph.D.
909-787-2585
Manuela.martins@ucr.edu
Lei Wang
951-823-9782
pyruvateust@gmail.com
Iqbal Pittalwala
Senior Public Information Officer
951-827-6050
iqbal@ucr.edu
Martins-Green will present, "Specific Pomegranate Juice Components as Potential Inhibitors of Prostate Cancer Metastasis," Sunday, Dec. 12, 2010, 11:30 a.m.- 1:00 p.m., Cancer Therapeutics, Exhibit Halls A/B/C, Program 653, Board B1037.
Co-Authors: L. Wang, J. Ho, A. Alcon, M. M. Martins-Green
Department of Cell Biology and Neuroscience, University of California, Riverside

John Fleischman | EurekAlert!
Further information:
http://www.ascb.org

More articles from Life Sciences:

nachricht Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)

nachricht CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>